Weblinks related to COVID-19 (this page is no longer maintained)

Switzerland

• Federal Office of Public Health: Information on the new coronavirus

  • German, French, Italian, English

• Federal council Point de Presse

• Federal government measures

  • German, French, Italian, English

• Swissmedic dedicated website to the COVID-19 pandemic

  • German, French, Italian, English

• Swiss National COVID-19 Science Task Force

  • German, French, English

International

• WHO global research on corona virus disease

• WHO European situation dashboard

• Johns Hopkins global cases

Guidances (EMA, MHRA, NHS, FDA, NHS, NIH)

• FDA guidance on conducting clinical trials during the pandemic

• EMA advice on clinical trials

• EMA Implications of coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials

• EMA MHA Guiance on the management of clinical trials during the COVID-19 pandemic (v3 28.04.2020)

• NHS guidance for sponsors, sites and researchers

• NIH guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19

• MHRA Advice for Management of Clinical trials in relation to Coronavirus

• COVID-19 Disruptions of International Clinical Trials: Comparing Guidances Issued by FDA, EMA, MHRA and PMDA, Mark Barnes et al. Ropes&Gray, April 2, 2020

Other guidances (other countries, other documents)

• EFGCP-AWP Covid-19 Repository

• Regulatory – ethical considerations for ongoing trials during Pandemic, ECRIM

• European data protection board: Statement on the processing of personal data in the context of the COVID-19 outbreak

Clinical Research

• Covid-19 Literature Review, ECRIN (list updated every two weeks)

• ICMRA statement on the continuation of clinical trials, Dec, 2020

• International coordination needed to encourage conduct of large, decision-relevant COVID-19 clinical trials. EMA Press Release, May 15, 2020

• MDR Metadata Repository for clinical trial data objects, ECRIN (it includes Covid-19 data)

• Covid-19 Trials Registries ECRIN

• EU Covid-19 trials coordination module (EU RESPONSE, RECOVER)

• Draft landscape of COVID 19 candidate vaccines, WHO

• Research mapping of candidate COVID-19 therapeutics, displaying studies per country, study design, disease severity in study participants, treatment comparisons, etc., Cochrane, Inserm, and others

• Living mapping and living systematic review of COVID-19 studies. Chochrane, Inserm, and others

• Covid-19: Infrastructure for real-world monitoring of treatments and vaccines, EMA

• Putative primary endpoints for RCTs involving medicines used for the treatment of COVID-19, ICMRA

Ethical guidances

• Statement of the Swiss National Advisory Commission on Biomedical Ethics (NEK/CNE) on political decisions on measures to contain the SARS-CoV-2 pandemic. Nr. 38/2021. March 15, 2021. In German, in French, in Italian

• Regulatory – ethical considerations for ongoing trials during Pandemic, ECRIM

• Key criteria for the ethical acceptability of COVID-19 human challenge studies. WHO Working Group for Guidance on Human Challenge Studies in COVID-19, WHO, May 6, 2020

• Position of the European Network of Research Ethics Committees (EUREC) on the Responsibility of Research Ethics Committees during the COVID-19 Pandemic, April 27, 2020 during the COVID-19 Pandemic, April 27, 2020

• Statement of the Swiss National Advisory Commission on Biomedical Ethics (NEK/CNE) on contact tracing. Nr. 33/2020. April 6, 2020. In German, in French, in Italian

• Nuffield Council on Bioethics. Webinar 'Ethics in the research response to COVID-19' April 3, 2020

• Guidance for research ethics committees for rapid review of research during public health emergencies. WHO, May 28, 2020

• Nuffield Council on Bioethics. COVID-19 antibody testing and ‘immunity certification’, webinar, July 2, 2020; policy briefing, June 18, 2020